ID   B1647
AC   CVCL_3357
DR   CLDB; cl7141
DR   ICLC; HTL03004
DR   Wikidata; Q54752456
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9332307;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ICLC=HTL03004
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D21S11: 30,31
ST   D5S818: 8,10
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=9332307; DOI=10.1046/j.1365-2141.1997.2793096.x;
RA   Bonsi L., Grossi A., Strippoli P., Tumietto F., Tonelli R.,
RA   Vannucchi A.M., Ronchi A., Ottolenghi S., Visconti G., Avanzi G.C.,
RA   Pegoraro L., Bagnara G.P.;
RT   "An erythroid and megakaryocytic common precursor cell line (B1647)
RT   expressing both c-mpl and erythropoietin receptor (Epo-R) proliferates
RT   and modifies globin chain synthesis in response to megakaryocyte
RT   growth and development factor (MGDF) but not to erythropoietin
RT   (Epo).";
RL   Br. J. Haematol. 98:549-559(1997).
//